Nanoparticle‐Based Radiosensitization in Breast Cancer: A Multimodal Approach to Therapy and Immune Regulation
Biotechnology Journal · 2026-05 · 21 (5)
DOI: 10.1002/biot.70242 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biotechnology Journal, online erschienen am 28.05.2026. Verfasst von Saleh A S AlAbdulhadi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department Medical Laboratory Science, University Prince Sattam Bin Abdulaziz, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Breast Neoplasms, Radiation-Sensitizing Agents, Metal Nanoparticles, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: King Khalid University.
Abstract (Originalsprache)
Radiotherapy is essential for breast cancer treatment, especially after lumpectomy. Its effectiveness, however, is hindered by tumor resistance, which causes recurrence and poorer outcomes. In the last decade, nanoparticle‐mediated radiosensitization has emerged as a promising strategy to improve radiotherapy in breast cancer. Metal nanoparticles, such as gold, silver, platinum, and bismuth, increase the localized radiation dose through secondary electron emission and generate reactive oxygen species (ROS). Polymeric, liposomal, and hydrogel nanocarriers deliver radiosensitizers directly to tumors with sustained release. These features increase cytotoxicity and reduce hypoxia‐related radioresistance. Nanoparticles also inhibit DNA repair pathways and modulate the tumor microenvironment, which enhances the radiation response. Additionally, nanoparticles can boost the effects of immunotherapy by activating dendritic cells, strengthening immune checkpoint blockade, and promoting anti‐tumor immune memory. Recent preclinical studies have shown that combining nanoparticles loaded with natural compounds, such as curcumin, polyphenols, flavonoids, and metformin, increases oxidative stress and radiosensitivity in breast tumors while sparing healthy tissue. We provide an overview of nanoparticle‐mediated radiosensitization mechanisms and novel supporting approaches for achieving better tumor responses with reduced toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department Medical Laboratory Science, University Prince Sattam Bin Abdulaziz, Riyadh, Saudi Arabia.
- Department of Pathological Analyses, Faculty of Science, University of Kufa, Najaf, Iraq.
- Scientific-Practical Medical Center for Pediatric Oncology, Hematology and Immunology, Tashkent, Uzbekistan.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
- Department of Chemistry and Biochemistry, School of Sciences, JAIN (Deemed to Be University), Bangalore, Karnataka, India.
- Department of Chemistry, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.
ORCID-Profile: Ali A Majeed, Reyadh R Al-Rashidi
Förderung
- King Khalid University
Zitieren
APA
AlAbdulhadi, S. A. S., Majeed, A. A., Polatova, D., Suliman, M., PadmaPriya, G., Jayabalan, K., Arora, V., Nayak, P. P., Al-Rashidi, R. R., & Kadhum, W. R. (2026). Nanoparticle‐Based Radiosensitization in Breast Cancer: A Multimodal Approach to Therapy and Immune Regulation. Biotechnology Journal, 21(5). https://doi.org/10.1002/biot.70242
Vancouver
AlAbdulhadi SAS, Majeed AA, Polatova D, Suliman M, PadmaPriya G, Jayabalan K, et al. Nanoparticle‐Based Radiosensitization in Breast Cancer: A Multimodal Approach to Therapy and Immune Regulation. Biotechnology Journal. 2026;21(5). doi:10.1002/biot.70242
BibTeX
@article{AlAbdulhadi2026,
author = {AlAbdulhadi, Saleh A S and Majeed, Ali A and Polatova, Djamila and Suliman, Muath and PadmaPriya, G and Jayabalan, Karthikeyan and Arora, Vimal and Nayak, Priya Priyadarshini and Al-Rashidi, Reyadh R and Kadhum, Wesam R},
title = {Nanoparticle‐Based Radiosensitization in Breast Cancer: A Multimodal Approach to Therapy and Immune Regulation},
journal = {Biotechnology Journal},
year = {2026},
volume = {21},
number = {5},
doi = {10.1002/biot.70242}
}
EUVIMED